Nimbus Therapeutics announced it has entered into a multi-year research collaboration and $1.3 exclusive license agreement ...

Nimbus and Eli Lilly collaborate to develop an oral treatment for obesity, leveraging computational chemistry and structure-based drug design. Nimbus Therapeutics and Eli Lilly announce their ...

By Exec Edge Editorial Staff Behind every scientific breakthrough at Colossal Biosciences stands a question that transcends ...

In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to ...

VANCOUVER, BRITISH COLUMBIA / ACCESS Newswire / January 6, 2026 / Lobe Sciences Ltd. (CSE:LOBE)(OTCQB:LOBEF)(FWB:LOBE.F) ("Lobe" or the "Company"), a biopharmaceutical company advancing programs in di ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

Leading market research agency strengthens leadership team to accelerate growth and innovation We have an exceptional team, a strong client portfolio, and significant opportunities ahead.” — Nicky ...

A team of cancer biologists led by Princeton’s Yibin Kang has resolved a confounding paradox about retinoids and cancer cells ...

Scientists at St. Jude Children's Research Hospital have revealed previously unappreciated roles for the retrotransposon LINE ...

The devastating Los Angeles fires in the very heart of a built-up urban interface sparked global interest, including in ...

Security Matters PLC is a pre-revenue company specializing in molecular traceability and authentication tech. See why SMX ...